• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心房利钠肽对体外培养的大鼠下丘脑乙酰胆碱诱导促肾上腺皮质激素释放因子释放的影响。

Effect of atrial natriuretic peptide on acetylcholine-induced release of corticotropin-releasing factor from rat hypothalamus in vitro.

作者信息

Takao T, Hashimoto K, Ota Z

机构信息

Third Department of Internal Medicine, Okayama University Medical School, Japan.

出版信息

Life Sci. 1988;42(12):1199-203. doi: 10.1016/0024-3205(88)90550-4.

DOI:10.1016/0024-3205(88)90550-4
PMID:2964553
Abstract

Effect of rat atrial natriuretic peptide (rANP) on acetylcholine-induced release of corticotropin-releasing factor (CRF) from the rat hypothalamus was studied in vitro using perifusion method. Perifused acetylcholine at 100 and 1000 ng/ml evoked significant CRF release, whereas norepinephrine at 10, 100 and 1000 ng/ml did not show a definite effect on CRF release. Continuous administration of alpha-rANP(1-28) (20ng/ml) inhibited the acetylcholine (100ng/ml)-induced CRF release. It is likely that ANP is involved in the regulation of CRF release.

摘要

采用体外灌流法研究了大鼠心房利钠肽(rANP)对乙酰胆碱诱导的大鼠下丘脑促肾上腺皮质激素释放因子(CRF)释放的影响。100和1000 ng/ml的灌流乙酰胆碱可引起显著的CRF释放,而10、100和1000 ng/ml的去甲肾上腺素对CRF释放未显示出明确影响。持续给予α-rANP(1-28)(20 ng/ml)可抑制乙酰胆碱(100 ng/ml)诱导的CRF释放。心房利钠肽可能参与了促肾上腺皮质激素释放因子释放的调节。

相似文献

1
Effect of atrial natriuretic peptide on acetylcholine-induced release of corticotropin-releasing factor from rat hypothalamus in vitro.心房利钠肽对体外培养的大鼠下丘脑乙酰胆碱诱导促肾上腺皮质激素释放因子释放的影响。
Life Sci. 1988;42(12):1199-203. doi: 10.1016/0024-3205(88)90550-4.
2
Stimulatory effect of acetylcholine on immunoreactive corticotropin-releasing factor release from the rat hypothalamus in vitro.
Life Sci. 1987 Feb 16;40(7):673-7. doi: 10.1016/0024-3205(87)90269-4.
3
Atrial natriuretic peptides inhibit the release of corticotrophin-releasing factor-41 from the rat hypothalamus in vitro.心房利钠肽在体外可抑制大鼠下丘脑促肾上腺皮质激素释放因子-41的释放。
J Endocrinol. 1990 Aug;126(2):223-8. doi: 10.1677/joe.0.1260223.
4
Inhibitory effect of norepinephrine on immunoreactive corticotropin-releasing factor release from the rat hypothalamus in vitro.去甲肾上腺素对体外培养的大鼠下丘脑免疫反应性促肾上腺皮质激素释放因子释放的抑制作用。
Life Sci. 1987 Apr 27;40(17):1645-9. doi: 10.1016/0024-3205(87)90012-9.
5
Acetylcholine and norepinephrine stimulate the release of corticotropin-releasing factor-41 from the rat hypothalamus in vitro.
Endocrinology. 1988 Oct;123(4):1962-9. doi: 10.1210/endo-123-4-1962.
6
Effects of atrial natriuretic factor on norepinephrine release in the rat hypothalamus.心房利钠因子对大鼠下丘脑去甲肾上腺素释放的影响。
Regul Pept. 1992 Sep 22;41(2):171-81. doi: 10.1016/0167-0115(92)90046-w.
7
Effect of acetylcholine and 5-hydroxytryptamine on the secretion of corticotrophin-releasing factor-41 and arginine vasopressin from the rat hypothalamus in vitro.乙酰胆碱和5-羟色胺对体外培养的大鼠下丘脑促肾上腺皮质激素释放因子-41和精氨酸加压素分泌的影响。
J Endocrinol. 1989 Sep;122(3):713-8. doi: 10.1677/joe.0.1220713.
8
Interleukin-2 (IL-2) induces corticotropin-releasing factor (CRF) release from the amygdala and involves a nitric oxide-mediated signaling; comparison with the hypothalamic response.
J Pharmacol Exp Ther. 1995 Feb;272(2):815-24.
9
In vitro study of immunoreactive corticotropin-releasing factor release from the rat hypothalamus.
Life Sci. 1985 Oct 21;37(16):1499-505. doi: 10.1016/0024-3205(85)90181-x.
10
Effect of noradrenaline and gamma-aminobutyric acid on the secretion of corticotrophin-releasing factor-41 and arginine vasopressin from the rat hypothalamus in vitro.去甲肾上腺素和γ-氨基丁酸对大鼠下丘脑体外分泌促肾上腺皮质激素释放因子-41和精氨酸加压素的影响。
J Endocrinol. 1989 Sep;122(3):719-23. doi: 10.1677/joe.0.1220719.

引用本文的文献

1
Central neuroregulation of hypothalamic corticotropin-releasing hormone (CRH-41) secretion.
J Endocrinol Invest. 1990 Oct;13(9):765-75. doi: 10.1007/BF03349619.